Second Annual Analysis of the Collaborative Islet Transplant Registry

N. Close, Rodolfo Alejandro, B. Hering, M. Appel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In September 2001, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) founded the Collaborative Islet Transplant Registry (CITR). Each year, CITR produces a complete set of analyses available to the public. In its second year, CITR represents the efforts of 19 North American islet transplant programs reporting information on 138 islet transplant recipients (1999-2004), 256 processed pancreata that led to infusion, and 266 infusion procedures. This analysis focuses on recipients of islet-alone procedures. Median age of the recipient is 41.6 years (range, 23.1-64.4 years), duration of diabetes is 29 years (range, 4-50 years), and over 66% are female. Median weight of the recipient is 65 kg (range, 47-97 kg) and median body mass index (BMI) is 23.1 kg/m2 (range, 18.8-31.6). Examining outcomes at 6 months following the recipient's last infusion, 67.0% are insulin independent, and at 12 months this percentage decreases to 58.0%. There is a striking decrease in the occurrence of severe hypoglycemic events subsequent to the first infusion. Over 82% of all recipients experience one or more severe hypoglycemic events in the year prior to their first infusion. However, only two recipients (2%) experience one or more severe hypoglycemic events between 30 days and 12 months postinfusion, but both of these recipients were on insulin replacement therapy and one had experienced a complete islet graft failure. The information provided in this analysis and subsequent analyses of CITR provides current and comprehensive information on outcome measures in islet transplantation.

Original languageEnglish
Pages (from-to)179-182
Number of pages4
JournalTransplantation Proceedings
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Registries
Transplants
Hypoglycemic Agents
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Insulin
Islets of Langerhans Transplantation
Pancreas
Body Mass Index
Outcome Assessment (Health Care)
Weights and Measures

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Second Annual Analysis of the Collaborative Islet Transplant Registry. / Close, N.; Alejandro, Rodolfo; Hering, B.; Appel, M.

In: Transplantation Proceedings, Vol. 39, No. 1, 01.01.2007, p. 179-182.

Research output: Contribution to journalArticle

Close, N. ; Alejandro, Rodolfo ; Hering, B. ; Appel, M. / Second Annual Analysis of the Collaborative Islet Transplant Registry. In: Transplantation Proceedings. 2007 ; Vol. 39, No. 1. pp. 179-182.
@article{18c633487ff647b69fb2444ce5cc7184,
title = "Second Annual Analysis of the Collaborative Islet Transplant Registry",
abstract = "In September 2001, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) founded the Collaborative Islet Transplant Registry (CITR). Each year, CITR produces a complete set of analyses available to the public. In its second year, CITR represents the efforts of 19 North American islet transplant programs reporting information on 138 islet transplant recipients (1999-2004), 256 processed pancreata that led to infusion, and 266 infusion procedures. This analysis focuses on recipients of islet-alone procedures. Median age of the recipient is 41.6 years (range, 23.1-64.4 years), duration of diabetes is 29 years (range, 4-50 years), and over 66{\%} are female. Median weight of the recipient is 65 kg (range, 47-97 kg) and median body mass index (BMI) is 23.1 kg/m2 (range, 18.8-31.6). Examining outcomes at 6 months following the recipient's last infusion, 67.0{\%} are insulin independent, and at 12 months this percentage decreases to 58.0{\%}. There is a striking decrease in the occurrence of severe hypoglycemic events subsequent to the first infusion. Over 82{\%} of all recipients experience one or more severe hypoglycemic events in the year prior to their first infusion. However, only two recipients (2{\%}) experience one or more severe hypoglycemic events between 30 days and 12 months postinfusion, but both of these recipients were on insulin replacement therapy and one had experienced a complete islet graft failure. The information provided in this analysis and subsequent analyses of CITR provides current and comprehensive information on outcome measures in islet transplantation.",
author = "N. Close and Rodolfo Alejandro and B. Hering and M. Appel",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.transproceed.2006.10.014",
language = "English",
volume = "39",
pages = "179--182",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Second Annual Analysis of the Collaborative Islet Transplant Registry

AU - Close, N.

AU - Alejandro, Rodolfo

AU - Hering, B.

AU - Appel, M.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - In September 2001, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) founded the Collaborative Islet Transplant Registry (CITR). Each year, CITR produces a complete set of analyses available to the public. In its second year, CITR represents the efforts of 19 North American islet transplant programs reporting information on 138 islet transplant recipients (1999-2004), 256 processed pancreata that led to infusion, and 266 infusion procedures. This analysis focuses on recipients of islet-alone procedures. Median age of the recipient is 41.6 years (range, 23.1-64.4 years), duration of diabetes is 29 years (range, 4-50 years), and over 66% are female. Median weight of the recipient is 65 kg (range, 47-97 kg) and median body mass index (BMI) is 23.1 kg/m2 (range, 18.8-31.6). Examining outcomes at 6 months following the recipient's last infusion, 67.0% are insulin independent, and at 12 months this percentage decreases to 58.0%. There is a striking decrease in the occurrence of severe hypoglycemic events subsequent to the first infusion. Over 82% of all recipients experience one or more severe hypoglycemic events in the year prior to their first infusion. However, only two recipients (2%) experience one or more severe hypoglycemic events between 30 days and 12 months postinfusion, but both of these recipients were on insulin replacement therapy and one had experienced a complete islet graft failure. The information provided in this analysis and subsequent analyses of CITR provides current and comprehensive information on outcome measures in islet transplantation.

AB - In September 2001, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) founded the Collaborative Islet Transplant Registry (CITR). Each year, CITR produces a complete set of analyses available to the public. In its second year, CITR represents the efforts of 19 North American islet transplant programs reporting information on 138 islet transplant recipients (1999-2004), 256 processed pancreata that led to infusion, and 266 infusion procedures. This analysis focuses on recipients of islet-alone procedures. Median age of the recipient is 41.6 years (range, 23.1-64.4 years), duration of diabetes is 29 years (range, 4-50 years), and over 66% are female. Median weight of the recipient is 65 kg (range, 47-97 kg) and median body mass index (BMI) is 23.1 kg/m2 (range, 18.8-31.6). Examining outcomes at 6 months following the recipient's last infusion, 67.0% are insulin independent, and at 12 months this percentage decreases to 58.0%. There is a striking decrease in the occurrence of severe hypoglycemic events subsequent to the first infusion. Over 82% of all recipients experience one or more severe hypoglycemic events in the year prior to their first infusion. However, only two recipients (2%) experience one or more severe hypoglycemic events between 30 days and 12 months postinfusion, but both of these recipients were on insulin replacement therapy and one had experienced a complete islet graft failure. The information provided in this analysis and subsequent analyses of CITR provides current and comprehensive information on outcome measures in islet transplantation.

UR - http://www.scopus.com/inward/record.url?scp=33846619654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846619654&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.10.014

DO - 10.1016/j.transproceed.2006.10.014

M3 - Article

C2 - 17275500

AN - SCOPUS:33846619654

VL - 39

SP - 179

EP - 182

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1

ER -